Although Biota filed their patent after Biocrysts, the US Patent Office awarded Biota the patent.
This cover's Biocryst's preclinical hep C candidate which caused its market cap to double in the past month or so.
Biocryst's Announcement
bta sticks a finger in biocryst's eye, page-2
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)